General
Preferred name
ENMD-981693
Synonyms
ENMD-2076 ()
ENMD 2076 ()
ENMD2076 ()
ENMD-2076 (Tartrate) ()
ENMD-2076 L-(+)-Tartaric acid ()
Enmd 2076 ()
P&D ID
PD011101
CAS
934353-76-1
1291074-87-7
1453868-32-0
Tags
obsolete probe
drug candidate
covalent binder
available
Drug indication
Acute myeloid leukaemia
Fibrolamellar liver cancer
Hepatocellular carcinoma
Triple negative breast cancer
Drug Status
investigational
Max Phase
Phase 2
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor. It inhibits a distinct profile of angiogenic tyrosine kinases in addition to the Aurora A kinase. These angiogenic targets include VEGFR, Flt3 and FGFR3 kinases, which have been shown to play important roles in the pathology of several cancers. (GtoPdb)
DESCRIPTION ENMD-2076 L-(+)-Tartaric acid is the tartaric acid of ENMD-2076, selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold more selective for Aurora A than Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 (BOC Sciences Bioactive Compounds)
Cell lines
2
Organisms
0
Compound Sets
22
AdooQ Bioactive Compound Library
A10352
BOC Sciences Bioactive Compounds
enmd-2076-l-tartaric-acid-cas-1291074-87-7-item-457865
Cayman Chemical Bioactives
22956
ChEMBL Drugs
CHEMBL482968
Clinical kinase drugs
Concise Guide to Pharmacology 2017/18
7885
Concise Guide to Pharmacology 2019/20
7885
Concise Guide to Pharmacology 2021/22
7885
Concise Guide to Pharmacology 2023/24
7885
CovalentInDB
CI005760
Drug Repurposing Hub
DrugBank
DB16891
DrugMAP
DMJZVPB
Guide to Pharmacology
7885
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL482968
LSP-OptimalKinase library (Laboratory of Systems Pharmacology)
CHEMBL482968
MedChem Express Bioactive Compound Library
HY-10987A
HY-10987
Novartis Chemogenetic Library (NIBR MoA Box)
Obsolete Compounds
enmd-2076
ReFrame library
Selleckchem Bioactive Compound Library
enmd-2076
enmd-2076-l-tartaric-acid
TargetMol Bioactive Compound Library
T2358
External IDs
36
Properties
(calculated by RDKit )
Molecular Weight
375.22
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
3.17
TPSA
72.97
Fraction CSP3
0.29
Chiral centers
0.0
Largest ring
6.0
QED
0.71
Structural alerts
1
historic compounds (Chemical Probes.org)
Obsolete
Related compounds
Custom attributes
(extracted from source data)
Targets
AURKA,FLT3
Pathway
Cell Cycle/Checkpoint
Angiogenesis
Apoptosis
Chromatin/Epigenetic
Tyrosine Kinase/Adaptors
Cell Cycle/DNA Damage
Epigenetics
Protein Tyrosine Kinase/RTK
Target
Aurora A
RET
FLT3
SRC
VEGFR3/FLT4
AURKA, FLT3, KDR, PDGFRA, PTK2, SRC
Aurora Kinase
FGFR
PDGFR
VEGFR
Apoptosis related,Aurora Kinase,CSF-1R,FGFR,FLT3,PDGFR,Src,VEGFR
Aurora Kinase,FLT3,VEGFR
Member status
virtual
MOA
Antimitotic Drugs
Aurora-A (ARK1) Kinase Inhibitors
Angiogenesis Inhibitors
Protein Kinase Inhibitors
Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor
Source data